Cargando…
Voriconazole-associated periostitis: Pathophysiology, risk factors, clinical manifestations, diagnosis, and management
Voriconazole use has been associated with osteoarticular pain and periostitis, likely due to high fluoride content in the drug formulation. This phenomenon has been described primarily with high dosage or prolonged course of voriconazole therapy in immunocompromised and transplant patient population...
Autores principales: | Guarascio, Anthony J, Bhanot, Nitin, Min, Zaw |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8465512/ https://www.ncbi.nlm.nih.gov/pubmed/34631468 http://dx.doi.org/10.5500/wjt.v11.i9.356 |
Ejemplares similares
-
Voriconazole‐Associated Periostitis: New Insights into Pathophysiology and Management
por: Bennett, Michael J, et al.
Publicado: (2021) -
Voriconazole-Induced Diffuse Periostitis
por: Stefan, Simona, et al.
Publicado: (2022) -
Voriconazole-induced periostitis post lung transplantation
por: Murray, Orla M., et al.
Publicado: (2022) -
Voriconazole-Induced Periostitis: A Case Report
por: Cooper-Roth, Tristan D, et al.
Publicado: (2023) -
Thoracic periosteal reaction secondary to voriconazole use in an adult transplant patient
por: Shetty, Anisha N., et al.
Publicado: (2023)